120 Participants Needed

Binocular Games for Lazy Eye

RJ
KK
Eileen E Birch, PhD profile photo
Overseen ByEileen E Birch, PhD
Age: < 18
Sex: Any
Trial Phase: Academic
Sponsor: Retina Foundation of the Southwest
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests new methods for treating lazy eye (amblyopia) using engaging binocular games. The researchers aim to determine if these games can help children achieve a more complete and lasting recovery. Participants will be divided into groups to try different game versions, with some receiving standard treatments and others testing new methods, such as Binocular Amblyopia Treatment. Children diagnosed with lazy eye, who have consistently worn glasses, and can play these games might be suitable candidates. As an unphased trial, this study provides a unique opportunity for children to explore innovative treatments that could enhance their recovery experience.

Will I have to stop taking my current medications?

The trial protocol does not specify whether you need to stop taking your current medications. However, you must be willing to stop patching treatment for the 12-week study period.

What prior data suggests that this binocular amblyopia treatment is safe?

Research has shown that treatments for lazy eye, such as those used in special games, are generally safe for children. One study found that a method called dichoptic balanced binocular viewing (BBV) was well-received by children with lazy eye. This method helps both eyes work together, and the study demonstrated that children and their families were willing to continue with the treatment.

Additionally, similar treatments, like Luminopia's virtual reality therapy, have received FDA clearance, indicating likely safety. This therapy involves watching favorite shows through a VR headset for short daily sessions and is approved for children aged 4 to 7. FDA approval suggests that the treatment is considered safe.

Overall, these treatments are designed to be child-friendly and have shown promising safety results in previous research.12345

Why are researchers excited about this trial?

Researchers are excited about the Binocular Amblyopia Treatment for lazy eye because it offers a fresh approach by using binocular games to enhance vision. Unlike traditional treatments that often rely on patching the stronger eye to force the weaker one to work harder, this method aims to train both eyes to work together. The treatment involves different contrast levels—standard, no increment, and reduced increment—to stimulate the visual system in new ways. This innovative approach not only promises a more engaging treatment experience but also targets the root of the vision imbalance, potentially leading to more effective and lasting improvements.

What evidence suggests that this trial's treatments could be effective for lazy eye?

This trial will compare different methods of binocular amblyopia treatment, which helps both eyes work together. Studies have shown that treating binocular amblyopia can lead to lasting improvements in vision. One study found that dichoptic stimulation improves cooperation between the eyes, enhancing vision. Another study showed that children using fun, game-like binocular treatment experienced similar vision improvements to those using traditional eye patching. Additionally, research suggests that these vision improvements remain stable even a year after treatment. This evidence supports the potential for binocular treatments to effectively improve vision in people with amblyopia, also known as lazy eye.46789

Are You a Good Fit for This Trial?

This trial is for children aged 4-10 with lazy eye, who have a certain level of vision in their amblyopic (weak) and fellow eyes. They must be able to play binocular games, have not received similar treatments recently, and agree to avoid patching during the study. Children with significant strabismus, premature birth history, other diseases or developmental delays cannot participate.

Inclusion Criteria

Parent's informed consent
Your "lazy" eye has a visual acuity between 0.3 and 0.8 on a special eye chart.
My child's eye doctor and we agree not to use patching treatment for 12 weeks.
See 7 more

Exclusion Criteria

I have an eye or other health condition alongside my main illness.
I have received treatment for lazy eye in the last 3 months.
You were born more than 8 weeks early.
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo binocular amblyopia treatment using contrast-rebalanced games for 8 weeks

8 weeks
Weekly visits for monitoring

Stereoacuity Training

Children achieving ≤0.4 logMAR at 8 weeks receive stereoacuity training

4 weeks
1 visit at 8 weeks, followed by training

Additional Amblyopia Treatment

Children with residual amblyopia receive dichoptic movies for further treatment

4 weeks
1 visit at 8 weeks, followed by treatment

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks
2 visits (in-person)

What Are the Treatments Tested in This Trial?

Interventions

  • Binocular Amblyopia Treatment
Trial Overview The trial tests if playing specially designed binocular games can more effectively treat lazy eye in kids compared to traditional methods. It aims for a complete and stable visual improvement over a 12-week period without using an eye patch.
How Is the Trial Designed?
3Treatment groups
Experimental Treatment
Active Control
Group I: Reduced Contrast IncrementExperimental Treatment1 Intervention
Group II: No Contrast IncrementExperimental Treatment1 Intervention
Group III: Standard Contrast IncrementActive Control1 Intervention

Binocular Amblyopia Treatment is already approved in United States for the following indications:

🇺🇸
Approved in United States as Luminopia for:
🇺🇸
Approved in United States as CureSight for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

Retina Foundation of the Southwest

Lead Sponsor

Trials
15
Recruited
1,600+

National Eye Institute (NEI)

Collaborator

Trials
572
Recruited
1,320,000+

Published Research Related to This Trial

In a study involving 25 children aged 8 to 18 with amblyopia, the use of a self-administered perceptual learning video game did not lead to significant improvements in visual function compared to traditional patching methods.
While no overall benefits were observed, better compliance with the perceptual learning therapy was associated with some positive outcomes, suggesting that increasing adherence to treatment might enhance effectiveness in future studies.
Short-term Perceptual Learning Game Does Not Improve Patching-Resistant Amblyopia in Older Children.Lee, YH., Maniglia, M., Velez, F., et al.[2021]
In a study involving 182 children aged 4 to 6 years with amblyopia, the use of a binocular iPad game, Dig Rush, resulted in a greater improvement in amblyopic-eye visual acuity after 4 weeks compared to continued spectacle correction alone, with an adjusted difference of 0.5 logMAR lines.
After 8 weeks, the improvement in visual acuity was not significantly different between the two groups, suggesting that while the binocular treatment shows promise, further modifications may be needed to enhance its long-term efficacy.
A Randomized Trial of Binocular Dig Rush Game Treatment for Amblyopia in Children Aged 4 to 6 Years.Manny, RE., Holmes, JM., Kraker, RT., et al.[2023]
In a study involving 90 children aged 4-12 with amblyopia, the dichoptic treatment Luminopia One led to significant improvements in visual acuity, with best-corrected visual acuity (BCVA) improving from 0.50 logMAR to 0.35 logMAR after 12 weeks (P < 0.0001).
The treatment also showed high adherence rates, with a median adherence of 86%, indicating that children were able to consistently engage with the therapy over the 12-week period.
Digital therapeutic improves visual acuity and encourages high adherence in amblyopic children in open-label pilot study.Xiao, S., Gaier, ED., Wu, HC., et al.[2021]

Citations

Binocular vision therapy for the treatment of Amblyopia—A ...Binocular vision therapy has led to lasting improvements in visual acuity and can be a useful adjunct, if not replacement, to the conventional treatment of ...
Binocular Approaches in Amblyopia Treatment Based on ...This approach, known as dichoptic stimulation, enables the treatment of amblyopia by facilitating the cooperation of both eyes.
Binocular Home Treatment for Amblyopia: Gains Stable for ...The main outcome measures were visual acuity (VA), stereoacuity, and amblyopia recurrence at 12- and 52-week post-treatment. Results. At 12-week ...
Comparative effectiveness of gamified binocular treatment ...The study indicates that GBT is as effective as patching in improving amblyopic visual outcomes among Chinese children 4 to 8 years of age.
Binocular Treatment of Amblyopia: A Report by the ...To review the published literature assessing the efficacy of binocular therapy for the treatment of amblyopia compared with standard treatments.
6.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/39079927/
results of a phase 2a randomised controlled feasibility trialThis study aimed to evaluate the safety of dichoptic balanced binocular viewing (BBV) for amblyopia in children, plus feasibility, adherence, acceptability, ...
7.luminopia.comluminopia.com/
Luminopia Binocular Therapy for AmblyopiaLuminopia is an FDA-cleared, binocular therapy that uses a VR headset to stream a child's favorite shows. Treatment is only one hour a day, six days a week.
Understanding Digital Treatments for AmblyopiaLuminopia Inc.'s virtual reality headset system is the first FDA-approved VR binocular therapy for amblyopia in children 4 to 7 years old.
CureSight amblyopia treatmentCureSight™ is an FDA cleared eye tracking based system designed for remote binocular vision treatment in pediatric patients (aged 4 to 9 years) suffering ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security